You must be 21 or older to view this site

By entering this site you accept the Terms of Service and Privacy Policy

Edward Rudnic, Ph.D.

During his 30 years as a pharmaceutical executive and entrepreneur, Dr. Rudnic has led several start-ups, public companies, and venture-related funds/companies, including MiddleBrook Pharmaceuticals, Shire Laboratories, and QRx Pharma. At Middlebrook Pharmaceuticals, he led the development of an FDA-approved, anti-infective product. At Shire, he was the lead inventor of Carbatrol/Equetro with cumulative sales of over $1,000,000,000 to date, and co-inventor of Adderall XR with cumulative sales of over $10 billion to date.

Prior to serving most recently as the Chief Operating Officer and CEO of QRx Pharma, Dr. Rudnic served in management roles at Merck (Schering-Plough) and Bristol Myers-Squibb (E.R. Squibb).